NAFDAC Warns Against Counterfeit Cancer Drug, Phesgo
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert regarding a counterfeit cancer treatment drug, Phesgo 600mg/600mg/10ml, with batch number C5290S20. In a statement (Alert No. 051/2024) on its website, NAFDAC revealed that Roche, the drug’s Marketing Authorisation Holder (MAH), flagged the counterfeit batch after receiving a complaint […]
